• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Scientists Develop Better Canine Flu Vaccines

February 2, 2017
Kerry Lengyel

Scientists have made progress in developing more effective vaccines to fight canine influenza virus.

Both humans and animals need proper vaccines to stave off unwanted diseases and viruses. While people have easy access to a flu shot each year to prevent influenza virus, dogs have not had an effective method to prevent canine influenza virus (CIV)—until now.

CIV, or dog flu, is a contagious respiratory disease caused by two strains of influenza.

  • H3N2 was adapted from avian influenza virus.
  • H3N8 originated from equine influenza virus.
Advertisement

Dogs can suffer from both a mild form of CIV that usually subsides in 2 to 3 weeks or a severe form that is usually accompanied by pneumonia and may prove fatal.

The only currently available vaccines to protect against CIV are inactivated vaccines, and the protection they provide is limited and short-lived.

Using a technique called “reverse genetics,” scientists from the University of Rochester School of Medicine and Dentistry have developed a live-attenuated canine influenza vaccine for use against the H3N8 strain of the virus. The live vaccine replicated in the nose but not in the lungs. The study results showed that the vaccine was safe, more effective than existing vaccines in preventing the H3N8 strain in mice, and provided better immune responses for longer periods of time.

In a second study, some of the same scientists got similar results when they created a second vaccine by removing the NS1 protein in the vaccine. This approach has been used with flu virus vaccines in other species.

Even though these studies proved successful, further studies and development are needed. Clinical trials of both these vaccines in dogs are the next step in development.

The first recognized CIV outbreak in the United States occurred at a greyhound racing track in Florida in January 2004. Since then, the virus has been reported in at least 40 states and Washington, DC, and has affected thousands of dogs. The H3N8 strain is currently circulating among dogs in the United States.

Although there is no evidence to date of CIV being transmitted from dogs to humans, the virus has shown the ability to adapt to different hosts; the H3N2 strain jumped from dogs to cats, and there is evidence that guinea pigs and ferrets can also become infected. Experts say that dogs that have been infected with multiple influenza viruses have the potential to generate strains that could infect people. Therefore, the Centers for Disease Control and Prevention continues to monitor the virus in animal shelters and in homes.


Advertisement

Latest News

Thriving when life is hard

Hospital design expert shares his favorite design element

Updated EquiTrace app integrates wth HISA Portal

San Francisco SPCA receives $100k grant from San Francisco Foundation

View More Latest News
Advertisement